https://simplecast.com Psychedelic Capital Join us for in-depth interviews with leading investors, entrepreneurs, researchers, and policymakers, pioneering a new future and healthcare with your host, Ross O'Brien, founder of Venture Capital firm, Bonaventure Venture Equity, author and lifelong entrepreneur. As an early investor in this new frontier, it's Ross's goal to share with you the conversations that he's having on an ongoing basis with the thought leaders and pioneers at this defining moment. We are in the midst of a mental health crisis, and an addiction crisis. Pain is an epidemic, and for the first time, we now have the legal pathways to develop psychedelic science to bring a new paradigm in medicine to the patients who need it most. As we imagine this new future, Ross is inspired every day by these visionaries and excited and privileged to introduce them to you. 2023 | Psychedelic Capital en Sat, 26 Aug 2023 14:27:02 +0000 Wed, 29 Jan 2025 18:31:12 +0000 https://psychedelic-capital.simplecast.com Psychedelic Capital https://image.simplecastcdn.com/images/bf0c0aa3-a8f6-466d-ae86-ebecc41ae726/9e65d1db-68ca-4b5e-a91c-1614dcfb7e9b/3000x3000/podcast-final.jpg?aid=rss_feed https://psychedelic-capital.simplecast.com episodic Join us for in-depth interviews with leading investors, entrepreneurs, researchers, and policymakers, pioneering a new future and healthcare with your host, Ross O'Brien, founder of Venture Capital firm, Bonaventure Venture Equity, author and lifelong entrepreneur. As an early investor in this new frontier, it's Ross's goal to share with you the conversations that he's having on an ongoing basis with the thought leaders and pioneers at this defining moment. We are in the midst of a mental health crisis, and an addiction crisis. Pain is an epidemic, and for the first time, we now have the legal pathways to develop psychedelic science to bring a new paradigm in medicine to the patients who need it most. As we imagine this new future, Ross is inspired every day by these visionaries and excited and privileged to introduce them to you. Ross O'Brien true https://feeds.simplecast.com/8V8jEKl1 Ross O'Brien conx@podconx.com 9ef4c58a-ad3c-4144-9453-00d80e5dd54f Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry "Balancing Medical Promise and Regulatory Complexity in the Psychedelics Landscape"

The "Psychedelics Capital Podcast" host Ross O'Brien  from Bonaventure Equity interviews Michael Werner from Holland & Knight, discussing the regulatory landscape for psychedelics. Michael, a partner at the law firm, explains that while the FDA sees itself as a public health agency focused on ensuring safe and effective products, the DEA approaches controlled substances like psychedelics from a law enforcement perspective due to their potential dangers. He highlights that while many drugs, including psychedelics, have potential benefits, the FDA emphasizes the importance of rigorous clinical trials to establish their safety and efficacy, particularly in a landscape where recreational and unregulated use is also prevalent.

 

Produced by PodConx

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Michael Warner - https://www.linkedin.com/in/michael-werner-a402189/

Holland & Knight - https://www.hklaw.com/

]]> Sat, 26 Aug 2023 14:27:02 +0000 conx@podconx.com (Michael Werner) https://psychedelic-capital.simplecast.com/episodes/navigating-regulatory-challenges-and-ensuring-safety-in-the-psychedelics-industry-wvoUucS_ "Balancing Medical Promise and Regulatory Complexity in the Psychedelics Landscape"

The "Psychedelics Capital Podcast" host Ross O'Brien  from Bonaventure Equity interviews Michael Werner from Holland & Knight, discussing the regulatory landscape for psychedelics. Michael, a partner at the law firm, explains that while the FDA sees itself as a public health agency focused on ensuring safe and effective products, the DEA approaches controlled substances like psychedelics from a law enforcement perspective due to their potential dangers. He highlights that while many drugs, including psychedelics, have potential benefits, the FDA emphasizes the importance of rigorous clinical trials to establish their safety and efficacy, particularly in a landscape where recreational and unregulated use is also prevalent.

 

Produced by PodConx

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Michael Warner - https://www.linkedin.com/in/michael-werner-a402189/

Holland & Knight - https://www.hklaw.com/

]]> Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry Michael Werner 00:54:59 "Balancing Medical Promise and Regulatory Complexity in the Psychedelics Landscape" The "Psychedelics Capital Podcast" host Ross O'Brien from Bonaventure Equity interviews Michael Werner from Holland & Knight, discussing the regulatory landscape for psychedelics. Michael, a partner at the law firm, explains that while the FDA sees itself as a public health agency focused on ensuring safe and effective products, the DEA approaches controlled substances like psychedelics from a law enforcement perspective due to their potential dangers. He highlights that while many drugs, including psychedelics, have potential benefits, the FDA emphasizes the importance of rigorous clinical trials to establish their safety and efficacy, particularly in a landscape where recreational and unregulated use is also prevalent. Produced by PodConx "Balancing Medical Promise and Regulatory Complexity in the Psychedelics Landscape" The "Psychedelics Capital Podcast" host Ross O'Brien from Bonaventure Equity interviews Michael Werner from Holland & Knight, discussing the regulatory landscape for psychedelics. Michael, a partner at the law firm, explains that while the FDA sees itself as a public health agency focused on ensuring safe and effective products, the DEA approaches controlled substances like psychedelics from a law enforcement perspective due to their potential dangers. He highlights that while many drugs, including psychedelics, have potential benefits, the FDA emphasizes the importance of rigorous clinical trials to establish their safety and efficacy, particularly in a landscape where recreational and unregulated use is also prevalent. Produced by PodConx holland & knight true full 5 1 1de59da8-2228-4ae8-bbbf-c9f65d436e97 Unleashing the Power of Psychedelics and AI: Revolutionizing Mental Health with Sensorium Therapeutics Exploring the Potential of Psychedelics and Natural Compounds

Dick Simon, the founder of Sensorium Therapeutics, discusses his journey and motivation in the field of psychedelics. Inspired by a friend's success with psychedelics in treating mental health issues, Dick embarked on a mission to advance research and de-stigmatization. He he joins Ross O'Brien  from Bonaventure Equity to talk about  co-founding Sensorium to create novel pharmaceuticals using a comprehensive database of psychoactive plants and fungi, leveraging artificial intelligence and machine learning for drug discovery. The company aims to have a significant impact in mental health and provide alternative treatment options for those who may not benefit from traditional psychedelics therapies.

Produced by PodConx

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Dick Simons - https://www.linkedin.com/in/dick-simon-6050ba5/

Sensorium Therapeutics - https://www.sensorium.bio/

 

]]> Thu, 6 Jul 2023 20:52:14 +0000 conx@podconx.com (Dick Simon) https://psychedelic-capital.simplecast.com/episodes/unleashing-the-power-of-psychedelics-and-ai-revolutionizing-mental-health-with-sensorium-therapeutics-NOJURCnA Exploring the Potential of Psychedelics and Natural Compounds

Dick Simon, the founder of Sensorium Therapeutics, discusses his journey and motivation in the field of psychedelics. Inspired by a friend's success with psychedelics in treating mental health issues, Dick embarked on a mission to advance research and de-stigmatization. He he joins Ross O'Brien  from Bonaventure Equity to talk about  co-founding Sensorium to create novel pharmaceuticals using a comprehensive database of psychoactive plants and fungi, leveraging artificial intelligence and machine learning for drug discovery. The company aims to have a significant impact in mental health and provide alternative treatment options for those who may not benefit from traditional psychedelics therapies.

Produced by PodConx

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Dick Simons - https://www.linkedin.com/in/dick-simon-6050ba5/

Sensorium Therapeutics - https://www.sensorium.bio/

 

]]> Unleashing the Power of Psychedelics and AI: Revolutionizing Mental Health with Sensorium Therapeutics Dick Simon 00:24:38 Exploring the Potential of Psychedelics and Natural Compounds Dick Simon, the founder of Sensorium Therapeutics, discusses his journey and motivation in the field of psychedelics. Inspired by a friend's success with psychedelics in treating mental health issues, Dick embarked on a mission to advance research and de-stigmatization. He he joins Ross O'Brien from Bonaventure Equity to talk about co-founding Sensorium to create novel pharmaceuticals using a comprehensive database of psychoactive plants and fungi, leveraging artificial intelligence and machine learning for drug discovery. The company aims to have a significant impact in mental health and provide alternative treatment options for those who may not benefit from traditional psychedelics therapies. Produced by PodConX Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Exploring the Potential of Psychedelics and Natural Compounds Dick Simon, the founder of Sensorium Therapeutics, discusses his journey and motivation in the field of psychedelics. Inspired by a friend's success with psychedelics in treating mental health issues, Dick embarked on a mission to advance research and de-stigmatization. He he joins Ross O'Brien from Bonaventure Equity to talk about co-founding Sensorium to create novel pharmaceuticals using a comprehensive database of psychoactive plants and fungi, leveraging artificial intelligence and machine learning for drug discovery. The company aims to have a significant impact in mental health and provide alternative treatment options for those who may not benefit from traditional psychedelics therapies. Produced by PodConx Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Bonaventure Equity - https://link.bve.vc/Visit-Us Dick Simons - https://www.linkedin.com/in/dick-simon-6050ba5/ Sensorium Therapeutics - https://www.sensorium.bio/ Exploring the Potential of Psychedelics and Natural Compounds Dick Simon, the founder of Sensorium Therapeutics, discusses his journey and motivation in the field of psychedelics. Inspired by a friend's success with psychedelics in treating mental health issues, Dick embarked on a mission to advance research and de-stigmatization. He he joins Ross O'Brien from Bonaventure Equity to talk about co-founding Sensorium to create novel pharmaceuticals using a comprehensive database of psychoactive plants and fungi, leveraging artificial intelligence and machine learning for drug discovery. The company aims to have a significant impact in mental health and provide alternative treatment options for those who may not benefit from traditional psychedelics therapies. Produced by PodConX Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Exploring the Potential of Psychedelics and Natural Compounds Dick Simon, the founder of Sensorium Therapeutics, discusses his journey and motivation in the field of psychedelics. Inspired by a friend's success with psychedelics in treating mental health issues, Dick embarked on a mission to advance research and de-stigmatization. He he joins Ross O'Brien from Bonaventure Equity to talk about co-founding Sensorium to create novel pharmaceuticals using a comprehensive database of psychoactive plants and fungi, leveraging artificial intelligence and machine learning for drug discovery. The company aims to have a significant impact in mental health and provide alternative treatment options for those who may not benefit from traditional psychedelics therapies. Produced by PodConx Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Bonaventure Equity - https://link.bve.vc/Visit-Us Dick Simons - https://www.linkedin.com/in/dick-simon-6050ba5/ Sensorium Therapeutics - https://www.sensorium.bio/ sensorium therapeutics true full 4 1 4efde2c6-dc6f-4301-98f9-3c71b96966cc Cliché Busting: Navigating the Legal Challenges of the Cannabis and Psychedelic Industries Jennifer Fisher and Bill Growney, two partners at Goodwin Proctor, a law firm specializing in the cannabis industry join Ross O'Brien  from Bonaventure Equity to talk about their practice and their work advising companies in the cannabis and psychedelic spaces. The conversation covers topics such as regulatory compliance, legal challenges, and unique challenges faced by emerging companies in these industries.

 

Produced by PodConX

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Jennifer Fisher - https://www.linkedin.com/in/jennifer-briggs-fisher-14843a/

Bill Growney - https://www.linkedin.com/in/billgrowney/

Goodwin Proctor - https://www.goodwinlaw.com/en

]]> Thu, 30 Mar 2023 04:00:00 +0000 conx@podconx.com (Jennifer Fisher, Bill Growney) https://psychedelic-capital.simplecast.com/episodes/cliche-busting-navigating-the-legal-challenges-of-the-cannabis-and-psychedelic-industries-yqTyfpAj Jennifer Fisher and Bill Growney, two partners at Goodwin Proctor, a law firm specializing in the cannabis industry join Ross O'Brien  from Bonaventure Equity to talk about their practice and their work advising companies in the cannabis and psychedelic spaces. The conversation covers topics such as regulatory compliance, legal challenges, and unique challenges faced by emerging companies in these industries.

 

Produced by PodConX

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Jennifer Fisher - https://www.linkedin.com/in/jennifer-briggs-fisher-14843a/

Bill Growney - https://www.linkedin.com/in/billgrowney/

Goodwin Proctor - https://www.goodwinlaw.com/en

]]> Cliché Busting: Navigating the Legal Challenges of the Cannabis and Psychedelic Industries Jennifer Fisher, Bill Growney 00:42:43 Jennifer Fisher and Bill Growney, two partners at Goodwin Proctor, a law firm specializing in the cannabis industry join Ross O'Brien from Bonaventure Equity to talk about their practice and their work advising companies in the cannabis and psychedelic spaces. The conversation covers topics such as regulatory compliance, legal challenges, and unique challenges faced by emerging companies in these industries. Produced by PodConX Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Bonaventure Equity - https://link.bve.vc/Visit-Us Jennifer Fisher - https://www.linkedin.com/in/jennifer-briggs-fisher-14843a/ Bill Growney - https://www.linkedin.com/in/billgrowney/ Goodwin Proctor - https://www.goodwinlaw.com/en Jennifer Fisher and Bill Growney, two partners at Goodwin Proctor, a law firm specializing in the cannabis industry join Ross O'Brien from Bonaventure Equity to talk about their practice and their work advising companies in the cannabis and psychedelic spaces. The conversation covers topics such as regulatory compliance, legal challenges, and unique challenges faced by emerging companies in these industries. Produced by PodConX Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Bonaventure Equity - https://link.bve.vc/Visit-Us Jennifer Fisher - https://www.linkedin.com/in/jennifer-briggs-fisher-14843a/ Bill Growney - https://www.linkedin.com/in/billgrowney/ Goodwin Proctor - https://www.goodwinlaw.com/en goodwin proctor true full 3 1 c029e7ef-17bb-452d-8079-aed591d9dcac Exploring the Future of Psychedelic Medicine: An Entrepreneur's Journey with Greg McKee In this episode host Ross O'Brien  from Bonaventure Equity interviews Greg McKee, the founder and CEO of Journey Life Sciences and a managing partner at Bonaventure Equity. O'Brien and McKee discuss the emerging world of psychedelics and venture capital, and the need for new paradigms of medicine to address the mental health, addiction, and pain epidemics. They talk about entrepreneurship and the importance of testing the market demand for new ideas, especially in the context of psychedelics as potential therapeutics. McKee shares his background in finance and drug development, and how he came to be interested in psychedelics. The episode concludes with a discussion of Journey's mission and how the company is working to bring psychedelic therapies to market.

Produced by PodConX

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Greg McKee - https://www.linkedin.com/in/gregorymmckee/

 

]]> Thu, 23 Mar 2023 04:00:00 +0000 conx@podconx.com (Greg McKee) https://psychedelic-capital.simplecast.com/episodes/exploring-the-future-of-psychedelic-medicine-an-entrepreneurs-journey-with-greg-mckee-hRnf8F6q In this episode host Ross O'Brien  from Bonaventure Equity interviews Greg McKee, the founder and CEO of Journey Life Sciences and a managing partner at Bonaventure Equity. O'Brien and McKee discuss the emerging world of psychedelics and venture capital, and the need for new paradigms of medicine to address the mental health, addiction, and pain epidemics. They talk about entrepreneurship and the importance of testing the market demand for new ideas, especially in the context of psychedelics as potential therapeutics. McKee shares his background in finance and drug development, and how he came to be interested in psychedelics. The episode concludes with a discussion of Journey's mission and how the company is working to bring psychedelic therapies to market.

Produced by PodConX

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Greg McKee - https://www.linkedin.com/in/gregorymmckee/

 

]]> Exploring the Future of Psychedelic Medicine: An Entrepreneur's Journey with Greg McKee Greg McKee 00:43:50 In this episode host Ross O'Brien from Bonaventure Equity interviews Greg McKee, the founder and CEO of Journey Life Sciences and a managing partner at Bonaventure Equity. O'Brien and McKee discuss the emerging world of psychedelics and venture capital, and the need for new paradigms of medicine to address the mental health, addiction, and pain epidemics. They talk about entrepreneurship and the importance of testing the market demand for new ideas, especially in the context of psychedelics as potential therapeutics. McKee shares his background in finance and drug development, and how he came to be interested in psychedelics. The episode concludes with a discussion of Journey's mission and how the company is working to bring psychedelic therapies to market. Produced by PodConX Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Bonaventure Equity - https://link.bve.vc/Visit-Us Greg McKee - https://www.linkedin.com/in/gregorymmckee/ In this episode host Ross O'Brien from Bonaventure Equity interviews Greg McKee, the founder and CEO of Journey Life Sciences and a managing partner at Bonaventure Equity. O'Brien and McKee discuss the emerging world of psychedelics and venture capital, and the need for new paradigms of medicine to address the mental health, addiction, and pain epidemics. They talk about entrepreneurship and the importance of testing the market demand for new ideas, especially in the context of psychedelics as potential therapeutics. McKee shares his background in finance and drug development, and how he came to be interested in psychedelics. The episode concludes with a discussion of Journey's mission and how the company is working to bring psychedelic therapies to market. Produced by PodConX Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Bonaventure Equity - https://link.bve.vc/Visit-Us Greg McKee - https://www.linkedin.com/in/gregorymmckee/ journey life sciences true full 2 1 ff104c51-2b58-4d8f-bf79-2743ef632fd6 Nick Norris Deep preparation, with a focus on integration and continued therapy

U.S. Navy SEAL veteran, entrepreneur, and founder of Protekt Products Nick Norris joins Ross O'Brien  from Bonaventure Equity to explain how psychedelic therapy helped him reignite his passions, restore his connection with his family, and give him a second chance at appreciating life.  He explains how Veterans Exploring Treatment Solutions (VETS) helps U.S. military veterans seeking psychedelic-assisted therapies for traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), addiction, and other health conditions.

Produced by PodConX

 

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Veterans Exploring Treatment Solutions (VETS) - https://vetsolutions.org/

Protekt - https://protekt.com/

 

 

]]> Thu, 9 Mar 2023 05:00:00 +0000 conx@podconx.com (Nick Norris, Ross O'Brien, POdConX, Dan Humiston) https://psychedelic-capital.simplecast.com/episodes/nick-norris-Nv8eAt4h Deep preparation, with a focus on integration and continued therapy

U.S. Navy SEAL veteran, entrepreneur, and founder of Protekt Products Nick Norris joins Ross O'Brien  from Bonaventure Equity to explain how psychedelic therapy helped him reignite his passions, restore his connection with his family, and give him a second chance at appreciating life.  He explains how Veterans Exploring Treatment Solutions (VETS) helps U.S. military veterans seeking psychedelic-assisted therapies for traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), addiction, and other health conditions.

Produced by PodConX

 

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Veterans Exploring Treatment Solutions (VETS) - https://vetsolutions.org/

Protekt - https://protekt.com/

 

 

]]> Nick Norris Nick Norris, Ross O'Brien, POdConX, Dan Humiston 00:53:08 Deep preparation, with a focus on integration and continued therapy U.S. Navy SEAL veteran, entrepreneur, and founder of Protekt Products Nick Norris joins Ross O'Brien from Bonaventure Equity to explain how psychedelic therapy helped him reignite his passions, restore his connection with his family, and give him a second chance at appreciating life. He explains how Veterans Exploring Treatment Solutions (VETS) helps U.S. military veterans seeking psychedelic-assisted therapies for traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), addiction, and other health conditions. Produced by PodConX Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Bonaventure Equity - https://link.bve.vc/Visit-Us Veterans Exploring Treatment Solutions (VETS) - https://vetsolutions.org/ Protekt - https://protekt.com/ Deep preparation, with a focus on integration and continued therapy U.S. Navy SEAL veteran, entrepreneur, and founder of Protekt Products Nick Norris joins Ross O'Brien from Bonaventure Equity to explain how psychedelic therapy helped him reignite his passions, restore his connection with his family, and give him a second chance at appreciating life. He explains how Veterans Exploring Treatment Solutions (VETS) helps U.S. military veterans seeking psychedelic-assisted therapies for traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), addiction, and other health conditions. Produced by PodConX Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Bonaventure Equity - https://link.bve.vc/Visit-Us Veterans Exploring Treatment Solutions (VETS) - https://vetsolutions.org/ Protekt - https://protekt.com/ veterans exploring treatment solutions (vets) true full 1 1 262b7f36-a5b9-4645-9984-31ba649b0c96 Trailer Welcome to Psychedelic Capital a show about investing in the new frontier of life sciences.  Premiering March 9th, join Bonaventure Capital's CEO Ross O'Brien as he tackles some of health cares biggest challenges with key thought-leaders, investors and entrepreneurs.  

Produced by PodConx

Ross O'Brien - https://www.linkedin.com/in/rossobrien/

Bonaventure Equity: Life Sciences Venture Capital - https://www.bve.vc/

Recorded on Squadcast

]]> Sun, 5 Feb 2023 23:08:05 +0000 conx@podconx.com (Ross O'Brien) https://psychedelic-capital.simplecast.com/episodes/trailer-Bqf8fYc0 Welcome to Psychedelic Capital a show about investing in the new frontier of life sciences.  Premiering March 9th, join Bonaventure Capital's CEO Ross O'Brien as he tackles some of health cares biggest challenges with key thought-leaders, investors and entrepreneurs.  

Produced by PodConx

Ross O'Brien - https://www.linkedin.com/in/rossobrien/

Bonaventure Equity: Life Sciences Venture Capital - https://www.bve.vc/

Recorded on Squadcast

]]> Trailer Ross O'Brien 00:00:39 Welcome to Psychedelic Capital a show about investing in the new frontier of life sciences. Premiering March 9th, join Bonaventure Capital's CEO Ross O'Brien as he tackles some of health cares biggest challenges with key thought-leaders, investors and entrepreneurs. Produced by PodConx Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Bonaventure Equity: Life Sciences Venture Capital - https://www.bve.vc/ Recorded On Squadcast Welcome to Psychedelic Capital a show about investing in the new frontier of life sciences. Premiering March 9th, join Bonaventure Capital's CEO Ross O'Brien as he tackles some of health cares biggest challenges with key thought-leaders, investors and entrepreneurs. Produced by PodConx Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Bonaventure Equity: Life Sciences Venture Capital - https://www.bve.vc/ Recorded On Squadcast true trailer 1